221 related articles for article (PubMed ID: 26913443)
1. [Significance of ST2 in the Early Diagnosis and Treatment of Graft-Versus-Host Disease--Review].
Lu RQ; Guo R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):307-10. PubMed ID: 26913443
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
3. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
[TBL] [Abstract][Full Text] [Related]
4. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Aladağ Karakulak E; Demİroğlu H; Malkan UY; Akman U; Göker H; Büyükaşik Y
Turk J Med Sci; 2021 Feb; 51(1):355-358. PubMed ID: 32927932
[TBL] [Abstract][Full Text] [Related]
5. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
Vander Lugt MT; Braun TM; Hanash S; Ritz J; Ho VT; Antin JH; Zhang Q; Wong CH; Wang H; Chin A; Gomez A; Harris AC; Levine JE; Choi SW; Couriel D; Reddy P; Ferrara JL; Paczesny S
N Engl J Med; 2013 Aug; 369(6):529-39. PubMed ID: 23924003
[TBL] [Abstract][Full Text] [Related]
6. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
[TBL] [Abstract][Full Text] [Related]
7. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?
Toubai T; Tanaka J; Paczesny S; Shono Y; Reddy P; Imamura M
Curr Stem Cell Res Ther; 2012 May; 7(3):229-39. PubMed ID: 22023620
[TBL] [Abstract][Full Text] [Related]
8. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
9. Combination of ST2 With Organ-Specific Biomarker is More Sensitive and Specific for the Diagnosis of Acute Graft-vs-Host Disease.
Wang B; Yin Y; Li Y; Liang Z; Liu W; Sun Y; Dong Y; Ren H
Transplant Proc; 2023 Sep; 55(7):1706-1714. PubMed ID: 37385841
[TBL] [Abstract][Full Text] [Related]
10. Colonic graft-versus-host disease.
Ross WA; Couriel D
Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
Dander E; De Lorenzo P; Bottazzi B; Quarello P; Vinci P; Balduzzi A; Masciocchi F; Bonanomi S; Cappuzzello C; Prunotto G; Pavan F; Pasqualini F; Sironi M; Cuccovillo I; Leone R; Salvatori G; Parma M; Terruzzi E; Pagni F; Locatelli F; Mantovani A; Fagioli F; Biondi A; Garlanda C; Valsecchi MG; Rovelli A; D'Amico G
Oncotarget; 2016 Dec; 7(50):82123-82138. PubMed ID: 27893415
[TBL] [Abstract][Full Text] [Related]
12. Changes in protein serum levels during stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; Corrente F; Piccirillo N; Bacigalupo AP; Sica S; Chiusolo P
Eur J Clin Invest; 2017 Oct; 47(10):711-718. PubMed ID: 28796281
[TBL] [Abstract][Full Text] [Related]
13. Oral graft-versus-host disease.
Kuten-Shorrer M; Woo SB; Treister NS
Dent Clin North Am; 2014 Apr; 58(2):351-68. PubMed ID: 24655527
[TBL] [Abstract][Full Text] [Related]
14. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
Noor F; Kaysen A; Wilmes P; Schneider JG
J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for acute GVHD: can we predict the unpredictable?
Chen YB; Cutler CS
Bone Marrow Transplant; 2013 Jun; 48(6):755-60. PubMed ID: 22863728
[TBL] [Abstract][Full Text] [Related]
16. Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.
McDonald GB; Tabellini L; Storer BE; Lawler RL; Martin PJ; Hansen JA
Blood; 2015 Jul; 126(1):113-20. PubMed ID: 25987657
[TBL] [Abstract][Full Text] [Related]
17. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.
Etra A; El Jurdi N; Katsivelos N; Kwon D; Gergoudis S; Morales G; Spyrou N; Kowalyk S; Aguayo-Hiraldo P; Akahoshi Y; Ayuk F; Baez J; Betts BC; Chanswangphuwana C; Chen YB; Choe H; DeFilipp Z; Gleich S; Hexner E; Hogan WJ; Holler E; Kitko CL; Kraus S; Al Malki M; MacMillan M; Pawarode A; Quagliarella F; Qayed M; Reshef R; Schechter T; Vasova I; Weisdorf D; Wölfl M; Young R; Nakamura R; Ferrara JLM; Levine JE; Holtan S
Blood Adv; 2024 Jun; 8(12):3284-3292. PubMed ID: 38640195
[TBL] [Abstract][Full Text] [Related]
18. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
Etra A; Gergoudis S; Morales G; Spyrou N; Shah J; Kowalyk S; Ayuk F; Baez J; Chanswangphuwana C; Chen YB; Choe H; DeFilipp Z; Gandhi I; Hexner E; Hogan WJ; Holler E; Kapoor U; Kitko CL; Kraus S; Lin JY; Al Malki M; Merli P; Pawarode A; Pulsipher MA; Qayed M; Reshef R; Rösler W; Schechter T; Van Hyfte G; Weber D; Wölfl M; Young R; Özbek U; Ferrara JLM; Levine JE
Blood Adv; 2022 Jun; 6(12):3707-3715. PubMed ID: 35443021
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous manifestations of graft-versus-host disease].
Karrer S; Holler E; Szeimies RM
Med Klin (Munich); 2001 Aug; 96(8):457-66. PubMed ID: 11560046
[TBL] [Abstract][Full Text] [Related]
20. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
